Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04575285

Using EEG to Predict Depression Treatment Response to rTMS in Patients With Major Depression

Using EEG to Predict Depression Treatment Response to Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Major Depression

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Baptist Health South Florida · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Repetitive Transcranial Magnetic Stimulation (rTMS) is a promising, novel, non-invasive therapy for depression. The study is looking at changes in specific electroencephalogram parameters in depressed patients treated with rTMS can serve as predictors of depression treatment response among cancer patents undergoing rTMS treatment of depression.

Detailed description

The study will be a prospective, single arm trial in which a set of patients who will be treated for major depression using Repetitive Transcranial Magnetic Stimulation (according to FDA approved rTMS standard care practices) also will undergo EEG recording before Repetitive Transcranial Magnetic Stimulation treatment begins, and at the completion of treatment. The Hamilton Depression Rating Scale will be given to participants by the neuropsychiatrist at baseline and weekly intervals till the completion of treatment. The neuropsychiatrist investigators expect to see about 12 patients per year who meet treatment criteria for Repetitive Transcranial Magnetic Stimulation. Therefore, it is expected to recruit 24 subjects into the research study over a two-year period.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTElectroencephalogram (EEG)EEG measures brain activity by recording the spontaneous brain electrical activity and evoked responses non-invasively from the scalp. Reusable Tangle Free 10mm EEG Cup Electrodes will be placed on the subject's scalp using the 10-20 system montage.

Timeline

Start date
2020-04-01
Primary completion
2030-12-01
Completion
2031-12-01
First posted
2020-10-05
Last updated
2024-06-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04575285. Inclusion in this directory is not an endorsement.